Photo Rounds

Bright red cervix

A 22-year-old woman went to see her family physician (FP) for a Pap smear. The patient had been on an oral contraceptive pill for the past year with no complaints. Her periods were regular and her last menstrual period was 2 weeks earlier. During the pelvic exam, the FP noted a bright red cervix and used a colposcope to look more closely.

What's your diagnosis?


 

There weren’t any suspicious areas during the colposcopic examination and wet prep was normal; the FP concluded that this was an ectropion.

This patient’s ectropion was a variation of normal due to her young age and exposure to oral contraceptives. The Pap smear was sent along with screening tests for chlamydia and gonorrhea; all tests came back normal.

Ectropion is common in adolescents, pregnant women, and those taking estrogen-containing contraceptives. In some women, the juvenile type transformation zone persists into adulthood, or is present after trauma or childbirth, and is termed an ectropion. It has a reddish appearance that is similar to granulation tissue. It may contain gland openings, nabothian cysts, and islands of columnar epithelium surrounded by metaplastic squamous epithelium. Although usually asymptomatic, vaginal discharge and postcoital bleeding may occur.

An ectropion may be treated with ablation if significant discharge or postcoital bleeding is present after dysplasia and cancer have been ruled out.

Photo courtesy of EJ Mayeaux, MD. Text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Colposcopy–normal and noncancerous findings. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:525-529.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Recommended Reading

Postcoital spotting
MDedge Family Medicine
Post-lumpectomy radiotherapy benefits good-risk DCIS patients
MDedge Family Medicine
ICSI use without male factor infertility climbs, but births decline
MDedge Family Medicine
First expression of cardiovascular disease differs by gender
MDedge Family Medicine
Data scarce on risk modifiers for second primary cancers
MDedge Family Medicine
Aromatase inhibitors linked to cardiovascular disease
MDedge Family Medicine
CDC: Opioid use high among reproductive age women
MDedge Family Medicine
FDA’s new labeling rule: clinical implications
MDedge Family Medicine
Perinatal mood and anxiety disorders
MDedge Family Medicine
ACOG outlines new treatment options for hypertensive emergencies in pregnancy
MDedge Family Medicine